United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Dr. Reddy’s Labs signs deal worth up to $150m to sell E7777 rights to Citius Dr. Reddy’s Laboratories (Dr. Reddy’s Labs) has agreed to divest its rights to E7777, an engineered IL-2-diphtheria toxin… bySrinathSeptember 4, 2021
